MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Leukemia, Hematologic, Blood
Stemline Therapeutics- NASDAQ: STML
Organization & Developments: Stemline
Parents
Stemline Therapeutics- NASDAQ: STML
Children
2018: Stemline -9% on FDA approval with Boxed Warningseekingalpha.com
2018: Stemline Therapeutics: Derisked And Ready To Rally - Stemline Therapeutics (NASDAQ:STML)
2018: The company has a proprietary drug discovery platform called StemScreen, and the company has amassed a robust intellectual property portfolio.
2019: Stemline Therapeutics: Still A Believer_seekingalpha.com
Clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells.
Jumps
*Key People: Stemline
Finance & Acquisition: Stemline